Boston Scientific Corporation (LON:0HOY)

London flag London · Delayed Price · Currency is GBP · Price in USD
98.35
-0.56 (-0.57%)
At close: Nov 4, 2025
-0.57%
Market Cap112.31B
Revenue (ttm)14.39B
Net Income (ttm)2.08B
Shares Outn/a
EPS (ttm)1.39
PE Ratio54.09
Forward PE29.56
Dividendn/a
Ex-Dividend Daten/a
Volume1,147
Average Volume7,017
Open98.00
Previous Close98.91
Day's Range96.78 - 98.98
52-Week Range83.65 - 109.51
Beta0.61
RSI44.49
Earnings DateFeb 5, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1979
Employees 53,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HOY
Full Company Profile

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD Financial Statements

News

Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)

Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)

1 day ago - GuruFocus

Boston Scientific announces upcoming investor conference schedule

MARLBOROUGH, Mass. , Nov. 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.

2 days ago - PRNewsWire

Demographic Megatrend: Stocks Poised to Benefit From Global Aging

Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this powerful megatrend.

5 days ago - Nasdaq

BSX December 12th Options Begin Trading

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the December 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BS...

6 days ago - Nasdaq

Ellen Zane Sells Shares of Boston Scientific Corp

Ellen Zane Sells Shares of Boston Scientific Corp

7 days ago - GuruFocus

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 5.86% on an annualized basis producing an average annual return of 18.39%. Currently, Boston Scientific has a marke...

7 days ago - Benzinga

Baron Health Care Fund Q3 2025 Top Contributors And Detractors

Argenx SE is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. RadNet, Inc. is the largest operator of outpatient diagno...

9 days ago - Seeking Alpha

Boston Scientific: Continuing Its M&A Playbook, As Organic Achievements Impress

Boston Scientific shows strong organic growth, margin expansion, and strategic acquisitions, trading at a premium with long-term potential. See why BSX stock is a hold.

12 days ago - Seeking Alpha

Boston Scientific Corporation (BSX) Announces Board Member John E. ...

Boston Scientific Corporation (BSX) Announces Board Member John E. Sununu's Decision Not to Seek Re-election

12 days ago - GuruFocus

Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst

On Wednesday, Boston Scientific Corporation (NYSE: BSX) reported third-quarter 2025 revenues of $5.07 billion, beating the consensus estimate of $4.97 billion . The medical technology giant reported ...

13 days ago - Benzinga

What the Options Market Tells Us About Boston Scientific

Deep-pocketed investors have adopted a bullish approach towards Boston Scientific (NYSE: BSX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga u...

13 days ago - Benzinga

Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why

Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

13 days ago - Nasdaq

These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings

Boston Scientific Corporation (NYSE:BSX) reported better-than-expected third-quarter results on Wednesday.

13 days ago - Benzinga

Boston Scientific (BSX) Surpasses Earnings Expectations in Q3 2025

Boston Scientific (BSX) Surpasses Earnings Expectations in Q3 2025

14 days ago - GuruFocus

Boston Scientific Corp (BSX) Q3 2025 Earnings Call Highlights: Strong Sales Growth and ...

Boston Scientific Corp (BSX) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Acquisitions Propel Performance

14 days ago - GuruFocus

Boston Scientific raises 2025 organic growth guidance to 15.5% amid WATCHMAN and EP momentum

Discover Boston Scientific's Q3 2025 earnings: double-digit revenue growth, raised guidance, and innovation in cardiovascular and MedSurg.

14 days ago - Seeking Alpha

Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Q3 2025 Earnings Call October 22, 2025 8:00 AM EDTCompany ParticipantsLauren Tengler - Director of Investor...

14 days ago - Seeking Alpha

Q3 2025 Boston Scientific Corp Earnings Call Transcript

Q3 2025 Boston Scientific Corp Earnings Call Transcript

14 days ago - GuruFocus

Boston Scientific (BSX) Surpasses Q3 Estimates and Hikes Full-Year Outlook

Boston Scientific (BSX) Surpasses Q3 Estimates and Hikes Full-Year Outlook

14 days ago - GuruFocus

Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says

Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance. Latest Ratings ... Full story available on Benzinga.c...

14 days ago - Benzinga

Wednesday's ETF Movers: IHI, BITQ

In trading on Wednesday, the iShares U.S. Medical Devices ETF is outperforming other ETFs, up about 3.3% on the day. Components of that ETF showing particular strength include shares of Intuitive Surg...

14 days ago - Nasdaq

Boston Scientific Jumps On Strong Guidance, Heart Devices Fuel Topline Growth

Boston Scientific Corporation (NYSE: BSX) reported third-quarter 2025 revenues of $5.07 billion on Wednesday, beating the consensus estimate of $4.97 billion. The medical technology giant reported ad...

14 days ago - Benzinga